Research Directory

ASCO 2024

Read more

New oncology drugs in pre-registration, late stage development

Read more

Interoperability - a way to improve clinical trials

Read more

EFPIA argues for better use of oncology endpoints

Read more

ASCO 2023 Strong data for lung and breast cancer drugs

Read more

Development timelines for new oncology drugs

Read more

Destiny Pharma advances strategy against bacteria

Read more

FDA guides on accelerated approvals in oncology

Read more

Checkpoint inhibitors are focus at ESMO

Read more

Viable malaria vaccine moves a step closer

Read more